Literature DB >> 14532253

Serial granulocyte transfusions as a treatment for sepsis due to multidrug-resistant Pseudomonas aeruginosa in a neutropenic patient.

Ying-Wei Lin1, Souichi Adachi, Ken-Ichiro Watanabe, Katsutsugu Umeda, Tatsutoshi Nakahata.   

Abstract

The emergence of multidrug-resistant Pseudomonas aeruginosa (MRPA) has become a major clinical problem. We successfully treated MRPA sepsis in a neutropenic patient undergoing peripheral blood stem cell transplantation with serial granulocyte transfusions. Granulocyte transfusion should be considered as a treatment for severe infection in patients with neutropenia.

Entities:  

Mesh：

Year:  2003        PMID： 14532253      PMCID： PMC254381          DOI： 10.1128/JCM.41.10.4892-4893.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Is it time for a new look at granulocyte transfusions?

Authors:  Jo-Anne H van Burik; Daniel J Weisdorf
Journal:  Transfusion       Date:  2002-11       Impact factor: 3.157

2.  Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation.

Authors:  T H Price; R A Bowden; M Boeckh; J Bux; K Nelson; W C Liles; D C Dale
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

3.  The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis.

Authors:  W I Bensinger; T H Price; D C Dale; F R Appelbaum; R Clift; K Lilleby; B Williams; R Storb; E D Thomas; C D Buckner
Journal:  Blood       Date:  1993-04-01       Impact factor: 22.113

4.  Extended high-level cross-resistance to antipseudomonal antibiotics amongst Pseudomonas aeruginosa isolates in a university hospital.

Authors:  D Sofianou; A Tsakris; L Skoura; J Douboyas
Journal:  J Antimicrob Chemother       Date:  1997-11       Impact factor: 5.790

5.  In-vitro interactions of DX-8739, a new carbapenem, meropenem and imipenem with amikacin against multiresistant Pseudomonas aeruginosa.

Authors:  E J Giamarellos-Bourboulis; P Grecka; H Giamarellou
Journal:  J Antimicrob Chemother       Date:  1996-08       Impact factor: 5.790

6.  Effects of storage of granulocytes on their fate in vivo.

Authors:  J McCullough; B J Weiblen; D Fine
Journal:  Transfusion       Date:  1983 Jan-Feb       Impact factor: 3.157

7.  Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors.

Authors:  Kai Hübel; Rachel A Carter; W Conrad Liles; David C Dale; Thomas H Price; Raleigh A Bowden; Scott D Rowley; Thomas R Chauncey; William I Bensinger; Michael Boeckh
Journal:  Transfusion       Date:  2002-11       Impact factor: 3.157

Review 8.  Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases.

Authors:  K Hübel; D C Dale; A Engert; W C Liles
Journal:  J Infect Dis       Date:  2000-12-08       Impact factor: 5.226

9.  Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey.

Authors:  G Bonfiglio; V Carciotto; G Russo; S Stefani; G C Schito; E Debbia; G Nicoletti
Journal:  J Antimicrob Chemother       Date:  1998-02       Impact factor: 5.790
  9 in total
  1 in total

Review 1.  Infections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation.

Authors:  Khalid Ahmed Al-Anazi; Asma M Al-Jasser
Journal:  Front Oncol       Date:  2014-07-14       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.